Insider Filings
Forms 3, 4 & 5
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2006 |
Director
Trans History: 77
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 399 | $37.25 | 2,489 |
| Jan 03, 2006 |
Director
Trans History: 30
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,610 | $37.25 | 12,403 |
| Jan 03, 2006 |
Director
Trans History: 136
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,610 | $37.25 | 8,515 |
| Jan 03, 2006 |
Director
Trans History: 136
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 637 | $37.25 | 19,598 |
| Dec 31, 2004 |
President &CEO, ACS
Trans History: 466
|
President &CEO, ACS | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 52 | $35.41 | 971 |
| May 15, 2024 |
Director
Trans History: 214
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 125,598 | $119.69 | 328,987 |
| May 15, 2024 |
Director
Trans History: 214
|
Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 96,977 | $203.42 | 232,010 |
| May 15, 2024 |
Director
Trans History: 214
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 28,500 | $203.96 | 203,510 |
| May 15, 2024 |
Director
Trans History: 214
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 25,329 |
| May 15, 2024 |
Director
Trans History: 214
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 1,928 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.